Kwality Pharmaceuticals Limited (NSE:KPL)
3,724.50
-28.30 (-0.75%)
Last updated: Sep 23, 2026, 3:29 PM IST
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 38.65 billion as of September 23, 2026. Its market cap has increased by 296.27% in one year.
Market Cap
38.65B
Enterprise Value
39.91B
Revenue
5.54B
Ranking
n/a
PE Ratio
47.69
Stock Price
3,724.50
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 38.65B, an increase of 16,642.02%. That is a compound annual growth rate of 65.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 38.65B | 236.09% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 74.38B |
| Innova Captab | 67.51B |
| Sun Pharma Advanced Research Company | 62.93B |
| Orchid Pharma | 50.20B |
| RPG Life Sciences | 46.35B |
| Solara Active Pharma Sciences | 35.80B |
| Ind-Swift Laboratories | 32.46B |
| Sakar Healthcare | 26.25B |